Table 1.
Experimental Period |
|||
---|---|---|---|
Group | Basal Period | Period 1 | Period 2 |
5-HT Levels in Liver (ng/mg protein) | |||
SAL | N/A | N/A | 543±141 |
L-ESC | N/A | N/A | 799±208 |
H-ESC | N/A | N/A | 908±72a |
Arterial Blood 5-HT (μg/L) | |||
SAL | 1140±283 | 1054±238 | 968±250 |
L-ESC | 835±176 | 835±165 | 702±126 |
H-ESC | 805±203 | 766±217 | 728±172 |
Portal Blood 5-HT (μg/L) | |||
SAL | 1235±322 | 1139±243 | 933±200 |
L-ESC | 873±149 | 780±126 | 733±123 |
H-ESC | 901±240 | 834±202 | 730±173 |
Hepatic Blood 5-HT (μg/L) | |||
SAL | 1268±299 | 1150±220 | 1041±226 |
L-ESC | 889±131 | 861±138 | 694±113 |
H-ESC | 945±230 | 861±175 | 769±197 |
Net Hepatic 5-HT Balance (μg/kg/min) | |||
SAL | 1.5±2.0 | 1.0±0.6 | 2.6±1.5 |
L-ESC | 0.7±1.8 | 1.8±1.1 | −0.7±1.4 |
H-ESC | 2.0±1.8 | 0.7±1.3 | 0.9±1.3 |
Data are mean ± S.E.M.. n=6 dogs in each group
Negative values for balance data indicate net hepatic uptake
Significant statistical difference (P<0.05) from the saline group